Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Windtree Therapeutics Inc (WINT)

Windtree Therapeutics Inc (WINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference GlobeNewswire - Mon Dec 16, 7:00AM CST

WINT : 0.3202 (-1.48%)
Windtree Therapeutics Files New Patent Application for Istaroxime Derivatives Aimed at Reducing Acute Myocardial Arrhythmia Risk Quiver Quantitative, Inc. - Mon Dec 9, 5:22PM CST

Windtree Therapeutics files a new patent application for istaroxime derivatives aimed at reducing acute myocardial arrhythmia risk.Quiver AI SummaryWindtree Therapeutics, Inc. has announced the filing...

WINT : 0.3202 (-1.48%)
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia GlobeNewswire - Mon Dec 9, 7:00AM CST

WINT : 0.3202 (-1.48%)
Windtree Therapeutics Engages New Growth Advisors to Explore Strategic Opportunities for Cardiovascular Portfolio Quiver Quantitative, Inc. - Wed Dec 4, 5:20PM CST

Windtree Therapeutics engages New Growth Advisors to explore strategic options for its cardiovascular portfolio, including potential asset sales or out-licensing.Quiver AI SummaryWindtree Therapeutics,...

WINT : 0.3202 (-1.48%)
Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction GlobeNewswire - Wed Dec 4, 7:00AM CST

WINT : 0.3202 (-1.48%)
Windtree Therapeutics Reports Positive Phase 2b Results for Istaroxime and Third Quarter 2024 Financials Quiver Quantitative, Inc. - Thu Nov 28, 1:20AM CST

Windtree Therapeutics reports positive results in istaroxime studies and addresses financial updates for Q3 2024.Quiver AI SummaryWindtree Therapeutics, Inc. reported positive developments for the third...

WINT : 0.3202 (-1.48%)
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates GlobeNewswire - Wed Nov 27, 3:05PM CST

WINT : 0.3202 (-1.48%)
Windtree Announces Leadership Transition Plan With Industry Veterans GlobeNewswire - Thu Nov 14, 7:00AM CST

WINT : 0.3202 (-1.48%)
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong GlobeNewswire - Mon Nov 4, 7:00AM CST

WINT : 0.3202 (-1.48%)
Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3 GlobeNewswire - Wed Oct 30, 7:00AM CDT

WINT : 0.3202 (-1.48%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot